# Phase 2 thyroid cancer trials recruiting: 20 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 20 trials in phase 2 for thyroid cancer that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 thyroid cancer trials: 20 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/thyroid-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 20
- Recruiting or not yet: 20
- Read on: November 19, 2026

## Trials

The 20 newest of 20, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 21, 2026 | NCT07886905 | Pulsed Stereotactic Ablative Radiotherapy (PULSAR) With Systematic Therapy for Thyroid Cancer | Washington University School of Medicine | Phase 2 | Not yet recruiting | Anaplastic Thyroid Carcinoma, Thyroid Cancer, Thyroid Carcinoma | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07886905) |
| October 14, 2026 | NCT07874321 | MRG003 Added to Ongoing Treatment After Progression in EGFR-Positive Advanced Thyroid Cancer | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 2 | Recruiting | Thyroid Cancer, Tumor, Advanced Thyroid Carcinoma | 39 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07874321) |
| August 20, 2026 | NCT07777536 | Selective Coverage Versus Comprehensive Coverage Radiotherapy in Poorly Differentiated and Anaplastic Thyroid Cancer | Fudan University | Phase 2 | Recruiting | Thyroid Cancer | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07777536) |
| November 19, 2025 | NCT07235566 | MRG003 and Pucotenlimab to Treat Locally Advanced or Metastatic ATC/PDTC | Fudan University | Phase 2 | Recruiting | Thyroid Cancer | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07235566) |
| September 25, 2025 | NCT07193186 | Anlotinib and Benmelstobart in DTC | Fudan University | Phase 2 | Not yet recruiting | Thyroid Cancer | 23 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07193186) |
| July 30, 2025 | NCT07092514 | Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differentiated Thyroid Cancer... | Washington University School of Medicine | Phase 2 | Recruiting | Thyroid Cancer, Cancer of the Thyroid | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07092514) |
| May 14, 2025 | NCT06970353 | Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer | Fudan University | Phase 2 | Recruiting | Radioactive Iodine-refractory, Differentiated Thyroid Cancer With NRAS Mutation, Advanced PDTC or ATC With NRAS Mutation | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06970353) |
| May 7, 2025 | NCT06961084 | Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer | Sponsor not shown (see the record) | Phase 2 | Recruiting | Thyroid Cancer | 62 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06961084) |
| May 6, 2025 | NCT06959511 | Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery | M.D. Anderson Cancer Center | Phase 2 | Recruiting | Neoadjuvant Treatment, Thyroid Cancer | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06959511) |
| April 11, 2025 | NCT06923826 | Sacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC) | National University Hospital, Singapore | Phase 2 | Recruiting | Salivary Gland Cancer, Thyroid Cancer | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06923826) |
| January 22, 2025 | NCT06787911 | Donafenib Combined With Anti-PD-1 Antibody for Neoadjuvant Therapy in Locally Advanced Thyroid Cancer | Sponsor not shown (see the record) | Phase 2 | Recruiting | Thyroid Cancer | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06787911) |
| December 3, 2024 | NCT06713057 | Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer | West China Hospital | Phase 2 | Not yet recruiting | Locally Advanced Thyroid Gland Carcinoma, Thyroid Cancer | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06713057) |
| June 13, 2024 | NCT06458036 | Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE) | Children's Hospital of Philadelphia | Phase 2 | Recruiting | Differentiated Thyroid Cancer, Pediatric Cancer, Cancer, Cancer, Thyroid | 13 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06458036) |
| October 17, 2023 | NCT06087068 | Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 | Recruiting | Thyroid Cancer, Surgery, Recurrence | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06087068) |
| August 23, 2023 | NCT06007924 | A Study of Avutometinib and Defactinib in People With Thyroid Cancer | Memorial Sloan Kettering Cancer Center | Phase 2 | Recruiting | Thyroid Cancer | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06007924) |
| March 24, 2023 | NCT05783323 | Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer | Children's Hospital of Philadelphia | Phase 2 | Recruiting | Differentiated Thyroid Cancer, Pediatric Cancer, Cancer, Cancer, Thyroid | 13 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05783323) |
| June 16, 2021 | NCT04927416 | The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 | Recruiting | Metastic Thyroid Cancer | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04927416) |
| February 15, 2019 | NCT03841617 | The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 | Recruiting | Thyroid Cancer | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03841617) |
| June 5, 2017 | NCT03175224 | APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors | Apollomics Inc. | Phase 2 | Recruiting | Solid Tumors, Advanced Cancer, Renal Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, NSCLC, Lung... | 497 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03175224) |
| April 4, 2017 | NCT03099356 | Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer | University of Michigan Rogel Cancer Center | Phase 2 | Recruiting | Metastatic Thyroid Cancer | 22 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03099356) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Fudan University | 4 |
| Children's Hospital of Philadelphia | 2 |
| Washington University School of Medicine | 2 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2 |
| University of Michigan Rogel Cancer Center | 1 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 1 |
| West China Hospital | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| M.D. Anderson Cancer Center | 1 |
| National University Hospital, Singapore | 1 |
| Apollomics Inc. | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 11 |
| China | 7 |
| Singapore | 2 |
| Australia | 1 |
| Canada | 1 |
| France | 1 |
| Hungary | 1 |
| Italy | 1 |
| Russia | 1 |
| Spain | 1 |
| Taiwan | 1 |
| United Kingdom | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Medical testing laboratories in the United States](https://specstream.ai/data/businesses/medical-testing-laboratories/united-states)
- [Metal suppliers in the United States](https://specstream.ai/data/businesses/metal-suppliers/united-states)
- [Montessori schools in the United States](https://specstream.ai/data/businesses/montessori-schools/united-states)
- [Music schools in the United States](https://specstream.ai/data/businesses/music-schools/united-states)
- [Nicaraguan restaurants in the United States](https://specstream.ai/data/businesses/nicaraguan-restaurants/united-states)
- [Occupational therapy clinics in the United States](https://specstream.ai/data/businesses/occupational-therapy-clinics/united-states)
